Allopregnanolone is primarily used in the treatment of postpartum depression (PPD), a severe form of depression that occurs after childbirth. It works by modulating the GABA-A receptors in the brain, which helps to restore normal brain activity and alleviate depressive symptoms. This neurosteroid is administered intravenously and has shown rapid and significant improvement in mood and overall mental health in women suffering from PPD. Additionally, allopregnanolone is being researched for its potential therapeutic effects in other mood disorders, such as major depressive disorder and anxiety disorders, due to its ability to enhance GABAergic neurotransmission. Its role in neuroprotection and its potential use in neurodegenerative diseases like Alzheimer's are also under investigation.